Analyst: Acceleron"s Blood Disorder Candidate Luspatercept Has Blockbuster Potential
Acceleron Pharma Inc (NASDAQ: XLRN) has a rich pipeline that positions the stock for additional upside, according to Piper Jaffray. Latest Ratings for XLRN.....»»
Acceleron"s luspatercept has blockbuster potential, says H.C. Wainwright
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
First data from trial of Moderna vaccine candidate for coronavirus could come by June: Evercore
The first set of immunogenicity data from the first trial of a potential vaccine to treat the coronavirus that causes COVID-19 could come as early as June, according to Evercore analyst Umer Ruffat. The National Institutes of Health.....»»
4 More Biotechs With Blockbuster Potential
Akero, Dermira, Global Blood Therapeutics and Moderna all have drugs that could hit $1 billion in salesRelated Stocks: AKRO, DERM, RHHBY, GBT, NVS, MRNA, MORF,.....»»
FDA approves Acceleron"s blood disorder drug ahead of schedule
The race to corner the market for a drug to treat a rare blood disorder escalated Friday, with the FDA signing off on a new drug from Cambridge’s Acceleron Pharma Inc. and its partner, Celgene Corp. The two drugmakers received early approval Fri.....»»
"Pleasantly Surprised" Acadia Analysts See Blockbuster Potential For Pimavanserin In Dementia Psychosis
ACADIA Pharmaceuticals Inc. Latest Ratings for ACAD DateFirmActionFromTo Sep 2019UpgradesHoldBuy Sep 2019MaintainsBuy Sep 2019MaintainsHold View More Analyst Ratings for ACAD View the Latest Analyst Ratings read more.....»»
Celgene And Acceleron: BLA Luspatercept Has Strong Potential
Celgene And Acceleron: BLA Luspatercept Has Strong Potential.....»»
Celgene & Acceleron Submit BLA for Luspatercept to the FDA
Celgene (CELG) and partner Acceleron submit BLA for pipeline candidate, luspaterc.....»»
Celgene, Acceleron shares rise on blood-disorder drug study
Celgene Corp. and Acceleron Pharma Inc. sh.....»»
Acceleron pops, Celgene shares higher after blood-disorder drug study results
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
AbbVie Gets OK for Potential Blockbuster Endometriosis Treatment
AbbVie Inc. won U.S. approval for an oral medicine that treats pain caused by the gynecological disorder endometriosis. AbbVie Inc. won U.S. approval for an oral medicine that treats pain caused by the gynecological disorder endom.....»»
Janney: Nightstar Therapeutics Has "Significant Upside Potential" With Retinal Disorder Treatments
Nightstar Therapeutics PLC (NASDAQ: NITE) leads the market in adeno-associated virus gene therapy for the treatment of inherited retinal disorders, according to a bullish Janney analyst.  Latest Ratings.....»»
Trump Vs. Biden: Latest Polls Don"t Bode Well For One Candidate In Tight Presidential Race
The upcoming 2024 presidential race may not favor former President Donald Trump, as recent polls suggest a potential defeat against current President Joe Biden. read more.....»»
Cardano"s Corrective Phase Could End Soon, Potential "Impressive Bull Run Ahead," Writes Analyst
Technical chart analyst Ali Martinez points out Cardano (CRYPTO: ADA) may be set for an impressive bull run like in 2019. read more.....»»
Amgen Outlook Is Bright, Analyst Predict Obesity-Focused Drug Potential Will Drive Shareholder Value
Amgen Inc (NASDAQ:AMGN) reported first-quarter (Q1) ear.....»»
Bitcoin Analyst Is Long On King Crypto As Fed Moves To Unwind Treasury Buybacks: "QE Is CLose"
Bitcoin (CRYPTO: BTC) analyst Michael van de Poppe takes a bullish stance on the cryptocurrency as the Federal Reserve begins unwinding Treasury buybacks, signaling a potential shift in monetary policy. read more.....»»
Bitcoin"s Historical Data Suggests A Potential 99% Surge, Says Crypto Analyst: "Time To Buy The Dip!"
As the cryptocurrency market continues to experience turbulence, Bitcoin (CRYPTO: BTC) might be on the brink of a significant upswing, according to historical data. read more.....»»
Enovix Stock Soars On Blockbuster Q1 Sales
Enovix reports quarterly losses of 31 cents per share which missed the analyst consensus estimate of losses of 29 cents by 6.9%. read more.....»»
Is Bitcoin Heading For A Dip Ahead Of FOMC? Analyst Predicts Potential "Cascade Towards $55-58K" Before Rebound
As the cryptocurrency market braces for the upcoming Federal Open Market Committee (FOMC) meeting, a prominent crypto analyst has made a bold prediction about Bitcoin‘s (CRYPTO: BTC) immediate future. read more.....»»
Whales On Vacation? Bitcoin Slumber Sparks Talk Of Price Explosion — Analyst Says This "Could Be The Spark Needed"
Crypto analysts have observed a significant decrease in Bitcoin (CRYPTO: BTC) whale activity since March 14, sparking speculation about a potential price surge soon. read more.....»»
Donald Trump Goes Off On One Candidate For Stealing Potential Votes Away From Him In Tight Race Against Joe Biden: "Would Essentially Be A WASTED PROTEST VOTE"
Last week, former President Donald Trump went on the attack against independent candidate Robert F. read more.....»»